Synthesis and Characterization of Complexes of New Derivative of Cyclopentaphenanthren-3-one with Manganese (II), Iron (II), Cobalt (II), Nickel (II), and Copper (II) Ions

Jassim, Liblab S.

doi:10.30684/etj.v38i3B.681

	Synthesis and Characterization of Complexes of New Derivative of Cyclopentaphenanthren-3-one with Manganese (II), Iron (II), Cobalt (II), Nickel (II), and Copper (II) Ions
Engineering and Technology Journal
Article 12, Volume 38, 3B, 2020, Pages 197-203 PDF (927.31 K)
Document Type: Research Paper
DOI: 10.30684/etj.v38i3B.681
Author
Liblab S. Jassim
Applied Chemistry Division, Department of Applied Sciences, University of Technology, Baghdad, Iraq
Abstract
This work involves the chemical preparation from a series of metal Complexes having the general composition M(L)2(H2O)2, where M = [Mn+2, Fe+2, Co+2, Ni+2 and Cu+2]. The ligand used was 9-fluoro-17-(1-hydrazono-2-hydroxyethyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[α]phenanthren-3-one (FHDTCP), who was diagnosed by H-NMR spectra. These complexes have been prepared and characterized by the ligand to metal by molar conductance, spectral (UV-Visible and FT-IR), and atomic absorption studies. The IR spectral measurements forecast interference to oxygen, nitrogen in coordination from the electron pairs to the metal ion in the center. And suggested the complexes geometry be octahedral for all.
Keywords
Dexamethasone; FHDTCP; Molar ratio

References
[1] F.C. Brownfoot, C.A. Crowther, P. Middleton, “Dexamethasone see Prednisone/Dexamethasone,” British Journal of Clinical Pharmacology, 30 (305), 5-16, 1990. [2] P.L. Havens, K.J. Wendel Berger, G.M. Hoffman, M. B. Lee, and M. J. Chasid, “Corticosteroids as Adjunctive Therapy in Bacterial Meningitis: A Meta-Analysis of Clinical Trials,” American Journal of Diseases of Children, 143(9), 1051-1055,1989. [3] N. Zhu, D. Zhang, and W. Wang, “A Novel Coronavirus from Patients with Pneumonia in China,” The new England Journal of Medicine, 382(4), 727-733,2019. [4] W. Choi, I. N. Houpis, A. Molina, J.E. Lynch, R. P. Volante, P.J. Reider and A.O. King, “Taking Stock of Maternal, Newborn, and Child Survival,” British Journal Clinical Pharmacology, 36(4), 4571,1995. [5] C. M. Oddo, “Intraneural Stimulation Elicits Discrimination of Textural Features by Artificial Fingertip in Intact and Amputee Humans,” Jundishapur Scientific Medical Journal, 5(3), 213-222, 2016 [6] U. Baschant, and J. Tuckermann, “The Role of the Glucocorticoid Receptor in Inflammation and Immunity,” Journal of Steroid Biochemistry, 1(12), 69-75, 2010. [7] J. K. Son, L.X. Zhao, A. Basnet, P. Thapa, R. Karki, and Y. Jahng, “Antenstal Corticosteroid Therapy for Fetal Maturation,” European Journal of Medicinal Chemistry, 43(6), 675-682, 2008. [8] M. Ciriaco, P. Ventrice, G. Russo, M. Scicchitano, G. Mazzitello, F. Scicchitano, and E. Russo “Corticosteroid-Related Central Nervous System Side Effects,” Journal of Pharmacology Pharmacotherapeutics, 15 (9), 654-668, 2013. [9] S. Diederich, B. Hanke, P. Burkhardt, M. Muller, M. Schoneshofer, V. Bahr and W. Oelkers, “Metabolism of Synthetic Corticosteroids by 11 Beta-Hydroxysteroid-Dehydrogenases in Man Steroids,” European Journal of Medicinal Chemistry, 63(6), 398-412, 1998. [10] P. M. Kistler, J. M. Kalman, S. P. Fynn, S. Singarayar, K. C. Roberts-Thomson, C. B. Lindsay, U. Khong, P. B. Sparks, N. Strathmore, and H. G. Mond, “Rapid Decline in Acute Stimulation Thresholds with Steroid-Eluting Active-Fixation Pacing Leads,” Pace-Pacing and Clinical Electrophysiology, 28(9), 903-909, 2005. [11] S. M. Spoorenberg, V. H. Deneer, J. C. Grutters, A. E. Pulles, G. P. Voorn, G. T. Rijkers, and W. J. Bos, “Pharmacokinetics of Oral vs. Intravenous Dexamethasone in Patients Hospitalized with Community-Acquired Pneumonia,” British Journal Clinical Pharmacology, 78(1), 78-83, 2014. [12] R. V. Singh, M. K. Biyala, and N. Fahmi.” Phosphorus, Sulfur and Silicon and the Related Elements”. American Journal of Diseases of Children, 180 (2), 425-434, 2005. [13] S. Mukhopadhyay, J. R. Hoidal, and T. K. Mukherjee, “Role of TNF-Alpha in Pulmonary Pathophysiology,” Respiratory Research, 7(1),125, 2006. [14] E. S. Tomlinson, J. L. Maggs, B. K. Park, and D. J. Back, “Dexamethasone Metabolism in Vitro: Species Differences,” Journal of Steroid Biochemistry Molecular Biology, 62 (4), 345-52, 1997. [15] A. Mahasin, K. Huda, and S. Carolin, “ Drug Discovery and Medicinal Chemistry for Psychiatric Disorders,” Journal of the Association of Arab Universities for Basic and Applied Sciences, 15(5), 28-34, 2014. [16] E. Yousif, A. Majeed, K. Al-Sammarrae, N. Salih, J. Salimon, and B. Abdullah, “Corticosteroids for Acute Bacteria Meningitis,” Arabian Journal of Chemistry, 10(2), S1639-S1644, 2017. [17] F. Nayeri, K. Movaghar-Nezhad, and F. Assar-Zadegan, “Effects of Antenatal Steroids on the Incidence and Severity of Respiratory Distress Syndrome in an Iranian Hospital,” Eastern Mediterranean Health Journal, 11(7), 716-722, 2005. [18] K. H. Yeh, C. C. Wang, M. S. Wen, C. C. Chou, S. J. Yeh, and D. L. Wu, “Long-Term Performance of Transvenous, Steroid-Eluting, High Impedance, Passive-Fixation Ventricular Pacing Leads,” Pace-Pacing and Clinical Electrophysiology, 27 (10), 1399-1404, 2004. [19] E. B. Fortescue, C. I. Berul, F. Cecchin, E. P. Walsh, J. K. Triedman, and M. E. Alexander, “Comparison of Modern Steroid-Eluting Epicardial and thin Transvenous Pacemaker Leads in Pediatric and Congenital Heart Disease Patients,” Journal of Interventional Cardiac Electrophysiology, 14(1), 27-36, 2005. [20] J. Liu, Z. C. Feng, and Q. Wang “Antenatal Dexamethasone has no Adverse Effects on Child Physical and Cognitive Development: a Long-Term Cohort Follow-up Investigation,” Journal of Maternal-Fetal and Neonatal Medicine, 25(11), 2369-2371 2012.
Statistics Article View: 297 PDF Download: 275